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Abstracts
11th Meeting of the Irish Society of Human 
Genetics, Friday 12th September 2008
Institute of Molecular Medicine, St. James’s Hospital, Dublin.
PROGRAMME: 
10.00 – 11.00  Registration / Tea and Coffee
11.00 – 11.05  Welcome
11.05 – 12.00  Spoken Presentations: Plenary I
12.00 – 13.00  Keynote address: “Genes for Blood Pressure”
  Professor Mark Caulfield, William Harvey Research 
Institute, London
13.00 – 14.00  Lunch and Poster viewing
14.00 – 15.30  Spoken Presentations: Plenary II
15.30 – 16.00  Tea and coffee / Poster viewing
16.00 – 16.15  Business Meeting
16.15 – 17.15  Keynote address: “Amyotrophic Lateral Sclerosis: 
Expanded Phenotypes and Complex Genetics” 
  Professor Orla Hardiman, National Centre for 
Neuroscience, Beaumont Hospital, Dublin
17.15 – 18.00  Wine reception / Presentation of Prizes / Meeting 
Close
SPOKEN PAPERS:
S1.  BiAllElic  dElEtiONS  Of  chROMOSOME  13q  ARE 
fREquENt  At  diAGNOSiS  iN  chRONic  lyMPhOcytic 
lEuKAEMiA.
Paula  Carty,  Johanna  Kelly,  Sarah  McCabe,  Natasha  Coen,  Claire 
Bermingham, Thomas Morris, David Betts
National  Centre  of  Medical  Genetics,  Our  Lady’s  Children’s  Hospital, 
Dublin, Ireland
Chronic  lymphocytic  leukaemia  (CLL)  represents  the  most  common 
leukaemia  in  the  western  world.  The  cytogenetic  analysis  for  specific 
karyotypic events plays an important part in the diagnostic work up of these 
patients. The most frequently described aberration in CLL, in about 50% of 
cases, are deletions of chromosome 13q. Since 2005, 313 patients at initial 
diagnosis have been investigated at the NCMG using a FISH panel that 
identifies the common CLL-associated aberrations. One or more aberrations 
were identified in 238 (77.6%) patients with a deletion of 13q present in 
185 (59.1%). Further analysis of the del(13q) patient subgroup showed a 
remarkable 53 (16.9%) with a biallelic 13q deletion population of cells. In 
23/53 patients a cell population with a monoallelic deletion of 13q was also 
evident. The group of patients with a biallelic deletion differed from the 
patients with solely a monoallelic deletion in having a notably lower incidence 
for the presence of other aberrations [2/53 (3.8%) vs. 23/134 (17.2%)]. This 
latter result indicates that the occurrence of a biallelic 13q deletion arises 
independently of other recognized aberrations. Given the high incidence of 
this aberration future studies are needed to assess whether this event has an 
associated prognostic significance. 
S2.  APPlicAtiON  Of ARRAy-cGh  fOR  thE  dEtEctiON 
Of  SuBMicROScOPic  chROMOSOMAl  iMBAlANcES 
iN  400  cASES  Of  childREN  with  idiOPAthic  MENtAl 
REtARdAtiON ANd cONGENitAl MAlfORMAtiONS.
Freddie Sharkey1,2, Nick Wilkie1, Eddy Maher1, David FitzPatrick2
1  Microarray  Facility,  South  East  Scotland  Cytogenetics  Unit,  Western 
General Hospital, Edinburgh EH4 2XU
2  Medical and Developmental Genetics Section, MRC Human Genetics 
Unit, Edinburgh EH4 2XU
The  advent  of  microarray  technology  has  revolutionised  molecular 
cytogenetics  in  recent  times,  accelerating  the  identification  of  cryptic 
chromosomal  rearrangements.  Enhanced  resolution  has  also  led  to 
the  identification  of  many  novel  new  microdeletion  and  duplication 
syndromes.  Detection  rates  for  chromosome  abnormalities  with  array-
CGH  in  constitutional  cytogenetics  range  from  5  -  20%  in  individuals 
with  normal  results  from  prior  routine  cytogenetics  testing. We  present 
BAC  array-CGH  data  from  approximately  400  cases  with  unexplained 
MR following karyotyping and subtelomere MLPA screening. We discuss 
the  identification  of  novel  submicroscopic  rearrangements,  low-level 
mosaicism, cryptic translocations, transmission of imbalances (1-4Mb) with 
no apparent phenotypic effect and the targeting of novel new microdeletion 
& reciprocal duplication syndromes. Large-scale array-CGH screening has 
also significantly increased our knowledge on the impact of copy number 
variants (CNVs), which represents one of the main challenges to differentiate 
between CNVs that are likely to be pathogenic, and CNVs that are less likely 
to contribute to an affected individual’s clinical presentation. With continual 
resolution changes, array-CGH will facilitate the identification of novel loci 
involved in MR and / or malformation syndromes and will provide important 
insights into the flexibility and plasticity of the human genome.
S3. Study Of thE KNOwlEdGE Of iNhERitEd MEtABOlic 
diSORdERS AMONG PAtiENtS ANd thEiR fAMiliES iN thE 
iRiSh POPulAtiON.
Rosie O’Shea1, Eileen Treacy2, Anne Marie Murphy2, Sally Ann Lynch3, 
Deborah Lambert2,3.
1  Department of Medical Genetics, Cardiff University,
2  Children’s University Hospital, Temple Street, Dublin
3  National Centre for Medical Genetics, Dublin.
Galactosaemia and Maple Syrup Urine Disease (MSUD) are recessively 
inherited conditions detected by newborn screening in Ireland.  Patients 
are  treated  at  one  centre  and  genetic  information  is  provided  by  the 
specialist team. We assessed knowledge among parents and patients to see 
whether referral for formal genetic counselling would be beneficial, using 
a  questionnaire  including  4  demographic,  8  knowledge,  2  information 
and  5  disease  impact  questions.    27  families  with  galactosaemia  and 
10 with MSUD were interviewed in clinic. All parents of children with 
galactosaemia and MSUD answered >75% of questions correctly, but there 
were misunderstandings about the risk or implications of carrier status. 
There was a significant difference in knowledge between ethnicities.  Adult 
patients  with  galactosaemia  had  more  misunderstandings  in  relation  to 
inheritance, recurrence risks and carrier status than their parents. 83% of 
study participants requested more information about their condition and its 
transmission. 40% of affected adults with galactosaemia identified a need 
to meet others with the same condition. While parents of children with 
MSUD or galactosaemia are well informed, the majority expressed a wish 
to be referred for genetic counselling. Adult patients with galactosaemia and 
parents from an Irish Travelling background could especially benefit. 
S4. ShOuld A fAMily hAvE tO fAcE A uv dilEMMA?
Claire W Kirk, Patrick J Morrison.
Northern Ireland Regional Genetics Centre, Belfast Health and Social Care 
Trust, A Floor, Belfast City Hospital, Lisburn Road, Belfast BT9 7AB.© The Ulster Medical Society, 2009.
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With  the  advancement  of  high-throughput  technologies  for  mutation 
screening, unclassified variants (UV; non-informative mutations for which 
the pathogenic effect is unclear) are increasingly being discovered in the 
BRCA1 and BRCA2 genes. There are a number of ways to try to establish 
the pathogenicity of a UV , including testing to see if the UV co-segregates 
with the disease in a family, checking a number of control samples to exclude 
its presence in the general population, and accessing websites designed for 
protein modelling and in silico functional analysis.
In those cases where pathogenicity cannot be established with certainty, there 
are issues around counselling and management of patients and their families. 
Genetic centres differ in their reporting policies, with some centres reporting 
all UVs to patients and others operating on a case-by-case basis. There does 
seem to be a general consensus that family history remains central to risk 
assessment and management of family members and that presymptomatic 
testing using UVs of uncertain clinical significance should not be offered. 
Here we present a case where a BRCA1 UV was found in a family member 
affected with breast cancer and discuss our decision regarding disclosure of 
the result and future management of the family.
S5. A  clOSER  lOOK At  MiSSiNGNESS: thE  iMPlicAtiONS 
Of  NON-RANdOM  MiSSiNGNESS  ON  fAlSE  POSitivE 
ASSOciAtiON  iN  GENOtyPE  cAlliNG APPROAchES  fOR 
GENOME widE ASSOciAtiON dAtA.
Richard Anney,  Elaine  Kenny,  Colm  O’Dushlaine,  Jessica  Su,  Barbara 
Franke, Ben Neale, Steven Faraone, Michael Gill.
Department  of  Psychiatry,  Neuropsychiatric  Genetics  Research  Group, 
Institute of Molecular Medicine & Trinity College Dublin, Ireland.
The considerable data-handling requirements for genome wide association 
studies (GWAS) prohibit individual calling of genotypes and create a reliance 
on  sophisticated  “genotype-calling  algorithms”.  Despite  their  obvious 
utility, the current genotyping platforms and calling-algorithms used are 
not without their limitations. Specifically, some genotypes are not called 
due to the ambiguity of the data. Any bias in the missing data could create 
spurious results. Using data from the Perlegen 600K Array - Genetic Analysis 
Information Network (GAIN) data - we observed that missing genotypes 
are not randomly distributed throughout the homozygous and heterozygous 
groups.  Using  simulation,  we  examined  whether  the  level  and  type  of 
missingness observed might influence deviation from the null-hypothesis 
under common case-control and family-based statistical approaches. Under a 
case-control model, where missingness is present in a case group but not the 
controls, we observed bias giving rise to genome-wide significant type-I error 
for missingness as low as 3%. The family-based association simulations show 
close to nominal type-I error at 4% genotype missingness. These findings 
have important implications to study design, quality-control procedures and 
reporting of findings in GWAS.
S6.  GENOME-widE  ASSOciAtiON  Study  uSEd  POOlEd 
dNA SAMPlES ANd itS APPlicAtiON iN cORONARy hEARt 
diSEASE.
W Meng1, A Hughes1, CC Patterson1, C Belton1, F Kee1, PP McKeown1,2.
1  Centre for Clinical and Population Sciences, Queen’s University Belfast, 
Institute of Clinical Science, Grosvenor Road, Belfast, BT12 6BJ, Northern 
Ireland, UK.
2  Regional Medical Cardiology Centre, Royal Victoria Hospital, Grosvenor 
Road, Belfast, BT12 6BA, Northern Ireland, UK. 
Background:  Genome-wide  association  studies  have  been  successful  in 
identifying  susceptibility  loci  for  common  diseases.  DNA  pooling  is  a 
practical way to reduce the huge cost of large-scale genotyping.
Methods: In the first stage, our work focused on the use of 330k / 550k SNP 
chips, using pooled DNA samples from up to 50 cases or controls. The cases 
were male patients with early-onset (<55yr) coronary heart disease. The 
control individuals (age > 68yr) were identified from the PRIME study. We 
then selected SNPs with differences of allele frequencies between 5% and 
13%, combined with a ‘cluster’ method. In the second stage, replication was 
undertaken using independent DNA samples from a family-based study (1494 
individuals from 580 families with probands having early-onset coronary 
heart disease). 
Results: Among 9 regions, SNPs in 2 chromosomal regions were successfully 
replicated in the second stage. The P values for SNPs in the DNAJC6 gene, 
rs501691, rs1325607, rs4325172 were 0.03, 0.03, and 0.004, respectively. 
Another SNP on chromosome 15, rs3825877 was also positive (P=0.009).
Conclusion: Genome-wide association studies using pooled DNA samples are 
feasible and may be a cost-effective way to detect genes for complex diseases. 
DNAJC6 gene may be associated with early-onset coronary heart disease. 
S7. POlyMORPhiSMS iN thE OxytOciN REcEPtOR GENE ANd 
AutiSM: ASSOciAtiON ANd fuNctiONAl StudiES.
Katherine Tansey 1, Matthew Hill, Richard Anney, Michael Gill & Louise 
Gallagher.
Department  of  Psychiatry,  Neuropsychiatric  Genetics  Research  Group, 
Institute of Molecular Medicine & Trinity College Dublin, Ireland.
The neuropeptide oxytocin has recently been implicated in the aetiology of 
autism.  We examined 20 markers in oxytocin receptor gene (OXTR) for 
association in 179 simplex families from the Irish Autism Study. We followed 
up genetic association studies with allelic expression imbalance (AEI) testing 
for alterations in expression of the OXTR gene.  Using lymphoblast cell lines 
from the CEU HapMap collection, we examined the influence of common 
variation and different levels of β-Estradiol and Progesterone on AEI.
We found associations between 3 SNPs in OXTR and autism (rs11720238 
p=0.031; rs7632287 p=0.0076; rs4564970 p=0.0091). Two SNPs showed 
association  with  a  high  functioning  subset  of  individuals  (rs11720238 
p-corrected= 0.025; rs7632287 p-corrected=0.0042). We observed AEI in 
OXTR. The variation in AEI was driven, in part, by a SNP in intron 3 of 
OXTR (rs237897; p=0.0265).  rs237897 was not associated with autism in 
our sample. The addition of hormones did not appear to alter AEI significantly 
from the baseline. 
These results confirm the importance of OXTR in the aetiology of autism 
and identify a SNP involved in differential gene expression.
S8. MOdElliNG ABERRANt SPliciNG iN MutANt GENES.
CE Willoughby, D O’Prey, DAC Simpson. 
Centre  for  Vision  Science,  Queen’s  University  Belfast,  Belfast,  United 
Kingdom.
Purpose:  Up  to  50%  of  all  point  mutations  responsible  for  genetic 
diseases  cause  aberrant  splicing.  The  aim  of  this  study  was  to  model 
the  pathological  impact  of  known  mutations  on  the  splicing  process  in 
genes  associated  with  Bardet-Biedl  syndrome  (BBS:  MIM  209900). 
Methods:  Computational  methods  were  applied  ‘in-silico’  to  prioritise 
and direct subsequent laboratory workup of mutations in BBS genes to 
establish which, if any, might have a pathogenic effect on splicing. Splice 
site score was calculated on 190 exons in 12 BBS genes using web-based 
servers  and  correlated  with  EST  evidence.  Computational  predictions 
of  aberrant  splicing  were  validated  in  vitro  using  a  minigene  system. 
Results:  290  mutations  were  modelled  and  21%  identified  ‘in-silico’  as 
potential mis-splicing mutations. BBS9, BBS10 and BBS5 genes contained 
the greatest percentage of possible splicing mutations with 75%, 33% and 
33%  respectively. A  number  of  predicted  aberrant  splicing  events  were 
modelled with a minigene system in HEK293 cell lines to validate predictions. 
Conclusions: Traditionally, mutation screening is based on genomic DNA 
analysis and the effect of a mutation on the mRNA or protein is usually 
predicted  from  the  primary  genomic  sequence,  as  opposed  to  direct 
experimental  evaluation  by  determining  mRNA  expression  and  splicing 
patterns. Here, we present an approach to predict and model aberrant splicing 
in mutant genes.
S9. fuNctiONAl ANAlySiS Of POlyMORPhiSMS iN GENES 
iMPlicAtEd iN PSychiAtRic diSORdERS.
Matthew Hill, Richard Anney, Michael Gill.
Department  of  Psychiatry,  Neuropsychiatric  Genetics  Research  Group, 
Institute of Molecular Medicine & Trinity College Dublin, Ireland.
Introduction: Psychiatric diseases such as autism, ADHD and schizophrenia 
are highly heritable. Past years have seen the identification of a handful of 
susceptibility genes via traditional candidate gene testing. With the advent 
genome-wide  associations  novel  susceptibility  genes  are  being  rapidly 
identified. In order to elucidate the molecular mechanisms giving rise to 
disease susceptibility it is necessary to identify and characterise functional 
genetic variation. To this end we sought to identify cis acting variation in 
‘traditional’ candidate genes and novel susceptibility genes using allelic 
expression imbalance (AEI).
Methods: HapMap CEU lymphoblast cell lines were used as a source of 
mRNA for measuring AEI for the nine selected genes; three monoaminergic 
genes, a recent schizophrenia susceptibility gene and five novel ADHD 
susceptibility genes were tested. AEI was determined using TaqMan SNP © The Ulster Medical Society, 2009.
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genotyping assays.
Results:  Significant AEI  was  observed  for  7/9  genes.  Only  COMT  and 
TRUB1  did  not  show AEI. A  SNP  in  CHI3L1,  rs4950928,  previously 
associated with schizophrenia was strongly associated with AEI.
Conclusion: We  have  identified  cis  acting  regulatory  events  in  multiple 
psychiatric disease susceptibility genes. These data will aid in both the 
future refinement of the association signal and elucidation of the molecular 
mechanisms underlying susceptibility.
S10.  dEvElOPMENt  Of  GENE thERAPiES  fOR  dOMiNANt 
dyStROPhic EPidERMOlySiS BullOSA.
CP Morgan, D Allen, PF Kenna, P Humphries, GJ Farrar.
Smurfit Institute of Genetics, Trinity College Dublin
Epidermolysis  Bullosa  comprises  a  group  of  rare  and  heritable  human 
blistering skin diseases, affecting up to 1 in 17,000 live births. The dominant 
dystrophic form of EB (dDEB) is characterised by mutations of the COL7A1 
gene,  resulting  in  production  of  mutant  type VII  collagen  protein. Any 
potential  dDEB  therapeutic  would  require  suppression  of  expression  of 
the mutant gene. Continuing advances in the field of gene therapy have led 
to the discovery of potential therapeutics for dominantly inherited human 
disorders: the method of RNA interference (RNAi) represents one such 
molecular tool for suppression of COL7A1 expression. RNAi is based on the 
sequence specific binding of synthetic RNA molecules to endogenous mRNA 
transcripts, causing their subsequent degradation. This study involved such 
suppression in human epidermal keratinocytes, using microRNA vectors 
expressing short hairpin RNAs targeting COL7A1. Subsequent evaluation 
of COL7A1 mRNA levels by real time rtPCR showed significant COL7A1 
suppression. Additionally, the expression levels of three interferon stimulated 
genes  were  evaluated  in  cells  transfected  with  the  COL7A1-targeting 
constructs. It was found that delivery of these potential therapeutics does not 
result in an interferon type-1 response. The results obtained thus far represent 
an important step in the progression towards a suitable therapy for dDEB.
POStER PRESENtAtiONS:
P1.  iNvEStiGAtiNG  PROMOtER  hyPERMEthylAtiON  Of 
APOPtOtic GENES iN PROStAtE cANcER.
TM Murphy1, AS Perry1  L O’Connor1, M Lawler.1
1Prostate Cancer Research Group, Institute of Molecular Medicine, Trinity 
Centre for Health Sciences, St. James Hospital, Dublin 8, Ireland.
It is now well established that cancer cells exhibit a number of genetic defects 
in the machinery that governs programmed cell death and that sabotage 
of apoptosis is one of the principal factors aiding in the evolution of the 
carcinogenic  phenotype. A  number  of  studies  have  implicated  aberrant 
DNA methylation as a key survival mechanism in cancer, whereby promoter 
hypermethylation  silences  genes  essential  for  many  processes  including 
apoptosis. To date, studies on the methylation profile of apoptotic genes 
have largely focused on cancers of the breast, colon and stomach, with only 
limited data available on prostate cancer. The aim of this study was to profile 
methylation of apoptotic-related genes in order to generate a prostate cancer 
“apoptotic methylation signature”. This in turn could play a role in the early 
detection and prognosis of prostate cancer and may help elucidate novel 
therapeutic targets. An in silico approach was first applied to generate a list 
of apoptotic genes. Relevant genes were identified based on the following 
criteria: 1) biological role in apoptosis, 2) the presence of a 5’ CpG Island   
3) susceptibility to promoter hypermethylation in other cancer types and 
4) down-regulation in prostate cancer. Under these criteria, 22 apoptotic-
related genes were identified as possible targets of methylation in prostate 
cancer. PCR assays were designed to amplify whole CpG islands in these 
gene promoters. Genes will be screened for CpG methylation in a panel of 
prostate cancer cell lines (LNCaP, DU145, PC-3, 22RV1, RC58) using an 
automated Denaturing High Performance Liquid Chromatography (DHPLC) 
instrument (WAVE®, Transgenomic Inc). To date, DHPLC results suggest 
that the CpG promoter region of TMS1, C-FLIP and BNIP3 are fully or 
partially methylated in the five cell lines examined, while APAF1, CASP8 
and CASP3 show no evidence of CpG promoter methylation. Currently we 
are screening BIK, DR4 and DR5 for promoter hypermethylation.
Genes of interest will be further validated through bisulfite sequencing and 
methylation levels quantified using quantitative methylation specific PCR in a 
prostate cancer biorepository that we have generated in Ireland, representing 
prostate cancer, normal adjacent prostate and benign prostatic hyperplasia. 
P2. ANAlyziNG illuMiNA huMAN 1M SNP dAtA fOR cNvS 
uSiNG RAw BEAd-lEvEl dAtA.
Naisha Shah1, Judith Conroy2, Regina Regan2, Sean Ennis2,3, Denis C Shields1
1  UCD  Conway  Institute  and  UCD  Complex  and  Adaptive  Systems 
Laboratory, School of Medicine and Medical Science, University College 
Dublin, Dublin, Ireland, 
2  Health Science, School of Medicine and Medical Science, University 
College Dublin, Dublin, Ireland, 
3  National  Centre  for  Medical  Genetics,  Our  Lady’s  Hospital  for  Sick 
Children, Dublin, Ireland
With  the  advent  of  high-throughput  genotyping  chips,  whole  genome 
association studies are undertaken to determine potential candidate loci by 
linking common SNPs and copy number variations to human disorders like 
autism. Illumina’s Human 1M SNP beadchip is one of the high-throughput 
genotyping chips popularly used. The genotype reproducibility for Human 
1M SNP chips is 99.99%. However, standard existing methods for prediction 
of  CNVs  from  the  normalized  intensity  data,  generated  by  Illumina’s 
proprietary software BeadStudio, have between   15-60% reproducible on 
experimental replicates depending on the algorithm used.  We are developing 
improvements in the pre-processing and normalization of raw intensity bead-
level data with respect to improving the CNV reproducibility of experimental 
replicates. In addition, we are optimizing the normalization of the SNP 
chip data to recover CNVs predicted using other experimental platforms.   
Applications to large clinical datasets of probands and parents as well as to 
HapMap datasets will be presented.
P3. A  fuNctiONAl  PROMOtER  POlyMORPhiSM  withiN 
Mthfd1 MAy iNcREASE NEuRAl tuBE dEfEct RiSK iN thE 
iRiSh POPulAtiON thROuGh AN iNtERActiON with thE 
R653q POlyMORPhiSM.
Nicola Carroll1, Faith Pangilinan2, Anne M. Molloy3, James Troendle4, James 
L. Mills4, Peadar N. Kirke5, Lawrence C. Brody2, John M. Scott6, Anne 
Parle-McDermott1.
1  Nutritional  Genomics  Group,  School  of  Biotechnology,  Dublin  City 
University, Dublin 9, Ireland. 
2  Molecular Pathogenesis Section, Genome Technology Branch, National 
Human Genome Research Institute, Building 50, Room 5306, 50 South 
Drive, MSC 8004, Bethesda, MD 20892-8004, USA. 
3  School of Medicine, Trinity College Dublin, Dublin 2, Ireland.
4  Eunice Kennedy Shriver National Institute of Child Health and Human 
Development, Bethesda, MD, USA. 5Child Health Epidemiology Division, 
Health Research Board, Dublin, Ireland.   6 School of Biochemistry & 
Immunology, Trinity College Dublin, Dublin 2, Ireland. 
Genetic  variants  in  MTHFD1  (5,  10-methylenetetrahydrofolate 
dehydrogenase/  5,  10-methenyltetrahydrofolate  cyclohydrolase/  10-
formyltetrahydrofolate  synthetase),  a  key  folate  metabolic  enzyme,  are 
associated with a number of pregnancy complications, including neural tube 
defects (NTDs). We have previously reported that a common polymorphism 
(dbSNP ID: rs1076991 CT), present in the core promoter region of the 
MTHFD1 gene, has a negative effect on gene transcription in vitro (ISHG 
meeting, 2006). We have since investigated this SNP as a potential risk factor 
for NTDs and report here that it is not an independent NTD risk factor in 
the Irish population, nor does it influence red cell folate or homocysteine 
levels. However, SNP-SNP interaction analysis with the previously identified 
disease-associated SNP rs2236225 GA (R653Q polymorphism) in the 
MTHFD1 gene revealed a highly significant association with NTD risk in 
both case and maternal groups (P < 0.001 and 0.01, respectively). These 
two SNPs are not in linkage disequilibrium and, therefore, the identified 
interaction cannot be attributed to simple co-segregation. Thus, although 
not an independent risk factor for NTDs, this SNP is relevant to elucidating 
the genetic component of common diseases through its interaction with the 
disease-associated R653Q polymorphism. 
P4. ABStRAct:  fuNctiONAl ASSESSMENt  Of  S100B AS A 
SuScEPtiBility GENE fOR PSychOtic BiPOlAR diSORdER.
E Dagdan1, P McKeon2,3, S Roche1,2
1  Smurfit Institute of Genetics, Trinity College, Dublin, Ireland;
2  Department of Psychiatry, Trinity College, Dublin, Ireland;
3  St. Patrick’s Hospital, Dublin, Ireland.
Introduction: The glial cell-derived neurotrophic factor, S100B, is implicated 
in the pathology of bipolar affective disorder (BPAD) and schizophrenia. 
S100B protein levels are elevated in serum of patients with both disorders © The Ulster Medical Society, 2009.
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and S100B variants are associated with schizophrenia. We previously reported 
association of a SNP in the promoter of S100B, rs3788266, with a psychotic 
form of BPAD (P=0.088). The disease-associated C allele disrupts a Trex/
MEF3 consensus recognition, which is bound by Six-family transcription 
factors, suggesting that it could affect S100B expression.
Methods: The functional effect of rs3788266 on S100B promoter activity 
was determined using the luciferase reporter system. Promoter fragments 
containing the T or C alleles of rs3788266 were subcloned into the pGL4.23 
minimal promoter-luciferase vector and were assayed for activity in U373MG 
glioblastoma cells. We also measured S100B RNA levels in post-mortem 
brain tissue and protein levels in serum to test for possible genotypic effects 
in vivo.  
Results: Luciferase reporter gene expression was significantly increased in 
the presence of the T compared to C allele (t= 4.151, P=0.001). However, 
preliminary data indicate that BPAD individuals with the TT genotype have 
lower mean serum S100B levels compared to those with the TC or CC 
genotypes (ANOVA: F=5.093, P=0.01). A similar pattern was observed at 
the RNA level but was not significant. 
Discussion:  The  disease-associated  C  allele  is  associated  with  reduced 
promoter activity in U373MG glial cells and increased protein levels in 
serum. SNP rs3788266 may represent a functional susceptibility variant that 
contributes to the increased S100B levels observed in BPAD patients. 
P5. fOuR cASES Of MOwAt-wilSON SyNdROME.
L Bradley, AJ Green, SA Lynch
National Centre for Medical Genetics, OLCHC, Dublin 12
Mowat-Wilson is a recently described multiple congenital anomaly condition 
with Hirschsprung disease as a hallmark feature. ZEB2 is the causative gene. 
We report 4 cases of Mowat-Wilson syndrome. Their age ranged from 22 
months to 5 years and 2 months. They all presented developmental delay, 
microcephaly, typical facial features and absent speech. Interestingly, none 
had Hirschsprung disease and only one had constipation.¾ had epilepsy which 
was well controlled and all of these also had congenital heart defects with 2 
requiring heart surgery. ¾ had brain imaging with no structural abnormalities 
were noted. 2/4 had ocular findings, 1 astigmatism and the other a strabismus. 
All had the typical affable personality. Their developmental delay was in the 
moderate to severe range.
All 4 were found to have de novo mutations in the ZEB2 gene. Three were 
novel mutations with 2 being frameshift and the other a nonsense mutation. 
The fourth mutation had previously been described and was also a nonsense 
mutation.
P6. vARiANtS iN thE NEStiN GENE ANd cORONARy hEARt 
diSEASE.
W Meng1, A Hughes1, CC Patterson1, C Belton1, PP McKeown1,2.
1  Centre for Clinical and Population Sciences, Queen’s University Belfast, 
Institute of Clinical Science, Grosvenor Road, Belfast, BT12 6BJ, Northern 
Ireland, UK.
2  Regional Medical Cardiology Centre, Royal Victoria Hospital, Grosvenor 
Road, Belfast, BT12 6BA, Northern Ireland, UK. 
Background: There is evidence that the intermediate filament protein, nestin, 
may play a role in tissue regeneration and nestin expression has been detected 
in coronary atherosclerotic plaques. However, to date, no population-based 
studies concerning the role of the nestin gene in coronary heart disease 
(CHD) have been reported. 
Methods: We evaluated 3 SNPs in the nestin gene amongst 1494 individuals 
in 580 Irish families with at least one member prematurely affected with 
coronary heart disease. Genotypes were determined by multiplex SNaPshot 
technology.
Results: Using the TDT/S-TDT test, we found that rs11582300 and rs3748570 
were associated with early-onset CHD (P=0.04 and P=0.02). 
Conclusion: We found that nestin gene variants were associated with early-
onset CHD. These findings emphasise the importance of further research to 
explore the role of nestin in atherosclerosis.
P7. iNvEStiGAtiON Of thE PutAtivE fuNctiONAl EffEct 
Of thE 19BP dElEtiON POlyMORPhiSM withiN iNtRON 1 Of 
thE dihydROfOlAtE REductASE (dhfR) GENE.
Alan Magee, Kirsty O’Brien, Anne Parle-McDermott.
Nutritional  Genomics  Group,  School  of  Biotechnology,  Dublin  City 
University, Ireland. 
DHFR  is  an  important  folate  metabolising  enzyme  that  catalyses  the 
conversion of dihydrofolate to tetrahydrofolate.  Folate genes are considered 
candidates  for  association  with  neural  tube  defects  (NTDs)  such  as 
spina  bifida  due  to  the  preventative  effect  of  periconceptional  maternal 
supplementation with folic acid.  Investigation of an intronic 19bp deletion 
polymorphism within the DHFR gene found a significant protective effect 
in mothers of NTD cases when present in one (Relative Risk 0.59 (95% CI: 
0.39-0.89), p= 0.01) or two copies (Relative Risk 0.52 (95% CI: 0.32-0.86), 
p= 0.01).  Analysis of mRNA levels revealed a small increase in expression 
(~1.5  fold)  associated  with  the  19bp  intronic  deletion  polymorphism, 
but  this  was  not  significant  (Parle-McDermott  et  al.,  Am  J  Med  Genet 
2007;143(11):1174-1180). 
We sought to further investigate the potential impact of the DHFR 19bp 
intronic  deletion  polymorphism  on  gene  expression  by  employing  a 
recombinant dual luciferase system in HEK293 cells.  The results of these 
experiments showed that the 19bp deletion showed a modest increase in 
reporter gene expression in agreement with the mRNA data.  It is proposed 
that the sequence of the 19bp deletion harbours an Sp2 binding site that acts 
as a repressor of transcription.  Mobility shift assays are being employed to 
directly test whether this polymorphism results in loss of an Sp2 binding 
site. 
P8.  uNcOMMON  PRESENtAtiON  fEAtuRES  Of thE t(8;14)
(q11.2;q32)  tRANSlOcAtiON  iN AcutE  lyMPhOBlAStic 
lEuKAEMiA (All).
Johanna Kelly1, Claire Bermingham1, Paula Carty1, Aengus O’Marcaigh2, 
Helen Enright3, David Betts1
1  National Centre of Medical Genetics, Our Lady’s Children’s Hospital, 
Dublin, Ireland, 
2  Department  of  Haematology  and  Oncology,  Our  Lady’s  Children’s 
Hospital, Dublin, Ireland, 
3  Adelaide and Meath Hospital, Dublin, Ireland
The  t(8;14)(q11.2;q32)  translocation  represents  a  rare  but  non-random 
event in ALL that results in a rearrangement of IGH on 14q32. Almost 
50% of reported cases occur in either Down syndrome (DS) associated or 
t(9;22)-positive disease. From a series of over 400 cases of ALL analysed at 
presentation by G-banding and/or FISH two were found to contain a t(8;14)
(q11.2;q32) translocation in either balanced or unbalanced form. Case 1 was 
an 18-year-old DS female who presented with a der(14)t(8;14) as the sole 
clonal aberration. The second case was a 49-year-old female who presented 
with t(9;22)-only as the minor stemline clone and a major sideline clone 
containing a t(8;14) in which the der(8) had a p arm deletion. Subsequent 
analysis of this case demonstrated only the presence of the t(9;22) stemline 
clone. This report further reinforces the association of the t(8;14)(q11.2;q32) 
with both t(9;22) and DS-associated ALL. As the standard der(8) was absent 
in both cases we speculate whether other cases with this translocation exist 
but were not fully characterised. The persistence of leukaemia without the 
rearrangement questions the importance of the event in the disease process. 
Further cases are needed to understand its potential relevance to the disease 
process and prognosis.
P9. AN APPROAch  tO  idENtify  NOvEl  huMAN  fOlAtE 
RESPONSivE GENES.
Christian Fiedler, Anne Parle-McDermott.
Nutritional  Genomics  Group,  School  of  Biotechnology,  Dublin  City 
University, Dublin 9, Ireland. 
The molecular details of how low folate status increases the risk of a range 
of common diseases such as neural tube defects, cardiovascular disease and 
colorectal cancer remains to be elucidated.  In a bid to begin to understand 
the  molecular  response  of  cells  to  a  restricted  supply  of  folate  that  is 
physiologically meaningful; an in vitro cell culture model of folate deficiency 
was employed in combination with gene expression profiling.  The nature of 
the experimental design ensures that the group of genes that initially respond 
to folate deficiency would be identified.  
A Coriell® lymphoblast cell line that was homozygous wildtype for the 
MTHFR 677C>T polymorphism (CC) was grown in folate sufficient or folate 
deficient media over a 12 day period. The folate deficient cells were grown in 
the presence of hypoxanthine and thymidine throughout the 12 day period to 
ensure the cells maintained a similar proliferation rate to the folate sufficient 
cells.  The hypoxanthine and thymidine were removed several hours prior to 
harvest on day 12.   Each condition was carried out in replicates of 5 yielding © The Ulster Medical Society, 2009.
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a total of 10 RNA samples for subsequent transcriptome profiling.  Each 
RNA sample was hybridisation to an individual Affymetrix Human Genome 
U133 Plus 2.0 array.  These arrays are one of the most comprehensive whole 
genome expression arrays; consisting of probe sets that represent over 47,000 
transcripts. 
The  resulting  data  signals  were  normalized  and  sufficient  and  deficient 
expression profiles were compared. A total of two gene lists were generated; 
each  subjected  to  stringent  or  less-stringent  statistical  parameters  and 
represent  genes  that  showed  a  consistent  differential  gene  expression 
pattern across the replicate samples.  The stringent list consists of 4 down-
regulated genes and 288 up-regulated genes.  The less-stringent list consists 
of 324 down-regulated genes and 597 up-regulated genes.  Based on the 
experimental design; these genes are likely to represent the initial cellular 
response to a depleted folate supply.  Further bioinformatics analysis and 
confirmation of expression differences by Quantitative RT-PCR are currently 
being performed. 
In conclusion, our approach has identified a list of novel folate responsive 
genes under conditions of relatively mild folate deficiency.  These genes/
pathways are likely to represent the initial response of a cell to low folate 
status.  These results will ultimately lead to a better understanding of how an 
individual’s folate status influences their disease risk.
P10. MOlEculAR ANAlySiS Of KERAtOcONuS iN NORthERN 
iRElANd.
DP Dash1, Sonia George3, G Silvestri1,3, J Jackson3, D Frazer3, AE Hughes2, 
CE Willoughby1,3
Centre for Vision Sciences1, Medical Genetics2, Queen’s University & Royal 
Victoria Hospital3, Belfast.
Purpose: Keratoconus (KC; MIM#148300) is the commonest reason for 
corneal transplantation in the Western world. Mutations in the visual system 
homeobox  gene  1  (VSX-1;  MIM#605020)  and  superoxide  dismutase  1 
(SOD1; MIM#147450) have been reported in KC. The purpose of this study 
was to perform a comprehensive screening of VSX-1 and SOD1 in KC 
patients and further molecular analysis of the chr15q22 linked to a Northern 
Irish family we mapped previously.  
Method: Index cases with KC were recruited and mutational analysis of 
VSX1 and SOD1 gene was carried out. Further candidate gene analysis was 
performed in chr15q22 interval and the region was analysed for copy number 
variations (CNV). 
Results: Four VSX1 sequence variants c.432C>G (p.D144E), c.479G>A 
(p.G160D), c.789C>T (p.S263S) were not seen in 100 healthy controls. 
Segregation was not detected for p.D144E and also for an intronic changes, 
c.844-13T>A. Although predicted to alter VSX1 splicing p.S263S had no 
effect on transcript processing. A silent mutation in SOD1 was detected in 
a familial KC patient and absent from 100 controls. Till date no pathogenic 
mutations and no CNV detected within the linkage region chr15q22.
Conclusions: VSX1 and SOD1 play a minor role in keratoconus pathogenesis. 
The  identification  of  the  genetic  basis  of  the  chr15q22  KC  family  is 
ongoing. 
P11. vitAMiN  d  REcEPtOR  POlyMORPhiSMS  fOK  1 ANd 
APA 1 hAvE NO ASSOciAtiON with SKiN cANcER iN RENAl 
tRANSPlANt PAtiENtS.
ME Laing, P Dicker, PJ Conlon, D Shields, GM Murphy. 
Beaumont Hospital, Dublin 9
Vitamin D has potent anti-tumour properties. Calcitriol (1,25(OH)2D3), 
the  hormonal  derivative  of  vitamin  D3,  is  an  antiproliferative  and 
prodifferentiation factor for several cell types, including human squamous 
cells  of  the  head  and  neck.  Several  polymorphisms  of  the  vitamin  D 
receptor have been described, including Fok 1, Taq 1, Apa 1 and Bsm. These 
polymorphisms have been reported to be associated with the occurrence 
and  outcome  of  malignant  melanoma1.  Bsm  BB  genotype  is  associated 
with  increased  squamous  cell  carcinoma  risk  2. We  have  examined  the 
frequency of FokI and ApaI polymorphisms in 401 renal transplant patients 
and measured the association with squamous cell carcinoma, basal cell 
carcinoma,  melanoma  and  also  renal  allograft  survival.  There  was  no 
association between patients with the polymorphism and the development 
of SCC, BCC or melanoma. There was however significantly improved graft 
survival at 3, 5 and 10 years for heterozygotes and homozygotes for the T 
allele (p=0.03) of Fok 1 Vitamin D polymorphism. This is the first time that 
the Fok I polymorphism has been associated with improved renal allograft 
survival. The finding is in keeping with a number of other related studies. 
In a retrospective study patients receiving 1,25(OH)2D3 along with standard 
immunosuppression had improved graft survival. There is also animal data 
showing prevention of chronic allograft rejection with use of Vitamin D 
receptor agonists. Any risk for skin cancer would be compounded for by the 
longer graft survival and is therefore a true negative association. 
1.   Osborne JE, Hutchinson PE. Vitamin D and systemic cancer: is this 
relevant to malignant melanoma? Br J Dermatol 2002;147(2):197-224. 
2. Han J, Colditz GA, Hunter DJ. Polymorphisms in the MTHFR and 
VDR genes and skin cancer risk. Carcinogenesis 2007;28(2):390-397
P12. PhENOtyPic vARiANtS iN MElAS.
Deirdre Donnelly, Shane McKee
Belfast City Hospital, Belfast BT9 7AB.
MELAS,  mitochondrial  encephalopathy,  lactic  acidosis  and  stroke-like 
episodes, is one of the commonest mitochondrial disorders.  The incidence 
is estimated to be around 1 in 15,000, but may be higher.  The age of 
presentation  and  symptomatology  vary  widely,  making  under-diagnosis 
likely.    Early-onset  stroke  is  the  commonest  presentation  in  adulthood.   
Presentation in childhood is more unpredictable and non-specific.  Early 
cardiac changes generally begin in childhood but are asymptomatic.  We 
report the case of an individual who was diagnosed following early-onset 
stroke and epilepsy.  The pedigree showed a brother with diabetes mellitus 
and a sister who died of cardiomyopathy.  Testing shows all family members 
to have a mt3243A>G mutation, the commonest mutation found in MELAS.   
All have had mutational load measurements in blood and urine.  Mutational 
load may influence prognosis, but does not always correlate with phenotype 
due to tissue heteroplasmy.  This family will be followed up closely, and 
will have mutational load measured annually.  Our patient is currently being 
treated with anti-epileptic medication, along with aspirin, L-arginine and 
thiamine. This family illustrates some of the many complexities in dealing 
with mitochondrial disorders.
P13.  A  fAMiliAl  t(2;9)(q37.3;q12)  tRANSlOcAtiON:  AN 
illuStRAtiON  Of  thE  POtENtiAl  liMitAtiONS  Of 
cOMMERciAlly AvAilABlE fiSh PROBES.
Adam Dunlop, Andrew Green, Gillian Clarke, David Betts
National  Centre  for  Medical  Genetics,  Our  Lady’s  Children’s  Hospital, 
Dublin, Ireland
The importance of cytogenetic family studies following the identification of 
either an inherited or de novo unbalanced chromosome abnormality is well 
documented. Conventional G-band analysis was performed on a 2 day old 
girl with dysmorphic features, frontal bossing and low set ears. The result 
indicated the presence of an additional chromosome, identified as del(9)(q12), 
“trisomy 9p”, a recognised syndrome that is typically considered to arise de 
novo and was consistent with her phenotypic features. G-band chromosome 
analysis was performed on both parents and showed a maternal reciprocal 
translocation t(2;9)(q37.3;q12). In an attempt to delineate the translocation 
further,  FISH  analysis  with  subtelomere  probes  mapping  to  2q  and  9q 
(TelVysion, Vysis) was undertaken. Unexpectedly, the 2q subtelomere region 
had not been translocated to the der(9). Given the breakpoints involved in this 
case, if only FISH and some molecular based studies were performed, the 
potential for a familial t(2;9) translocation would have remained unsuspected 
with significant consequences for this family. 
P14. ABNORMAlitiES Of 3q26 iN MyElOid MAliGNANcy: thE 
BElfASt ExPERiENcE.
SE McNerlan, P McGrattan, A Logan, M Humphreys
Northern Ireland Regional Cytogenetics Laboratory, Belfast Trust.
Rearrangements of chromosome 3q26, although well recognised in myeloid 
disease, are still relatively rare. They have been reported in AML, MDS, 
CML and other MPDs. They tend to be associated with tri-lineage dysplasia, 
prior treatment with alkylating agents, shorter survival time, poor response 
to  treatment  and  abnormal  expression  of  the  EVI1  gene.  However,  in 
the majority of patients demonstrating abnormal EVI1 expression, 3q26 
rearrangements are generally not detected cytogenetically. 
Since 1990 the Northern Ireland Regional Cytogenetics lab has investigated 
11 patients with 3q26 rearrangements. These patients (6 females and 5 males) 
suffered from a range of myeloid conditions including AML of various 
subtypes, MDS and transforming CML. Age of diagnosis ranged from 55 to 
86 years. Survival data was available for 7 patients and ranged from <1 to 
21 months post diagnosis.
Our experience therefore confirms the poor survival generally associated © The Ulster Medical Society, 2009.
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with 3q26 rearrangements and enforces the importance of establishing their 
presence at disease diagnosis and during treatment. Technical difficulties 
have  precluded  the  development  of  satisfactory  FISH  tests  in  the  past, 
however, new molecular technologies are now available. Considering the poor 
prognosis, routine introduction of these techniques for cultures that fail to 
grow or patients with a normal karyotype should therefore be considered.
P15. AN AttENuAtEd fORM Of MORquiO diSEASE SEEN iN 
NORthERN iRElANd.
Fiona Stewart1 Karen Tylee2 Aoife Bradley1 Alan Cooper2
1  Northern Ireland Regional Genetics Service, Belfast City Hospital,
2  Willink Biochemical Genetics Unit, Royal Manchester Children’s Hospital, 
Manchester.
Morquio disease (mucopolysaccharidosis type IV) is a lysosomal storage 
disorder causing predominantly skeletal manifestations.  It is caused by a 
deficiency of galactosamine-6-sulphate sulphatase. In the classical form of 
Morquio disease there is extreme short stature with average height being 
between 90 and 120 cm.  There are marked skeletal deformities and many 
affected individuals require surgery to stabilise their cervical spine. We have 
identified 6 individuals in Northern Ireland who have an attenuated form of 
the disease – two sets of siblings and two single cases.  Ages ranged from 
27 years to 38 years.  Height ranged from 142 cm to 160cm.  This form of 
the disease was initially considered relatively benign.  However it is now 
clear that affected individuals have major problems with their joints and 5/6 
patients have had at least one major joint replaced with two having had 3 
joints replaced. Our patients have also shown evidence of osteoporosis.  We 
will present biochemical and molecular data on the cases.
These  patients  were  all  initially  considered  to  have  spondyloepiphyseal 
dysplasia before the correct diagnosis of MPS IV was made.  
P16.  MultiPlEx  MASSARRAy  SPEctROMEtRy  (iPlEx) 
PROducES  A  fASt  ANd  EcONOMicAl  tESt  fOR  thE 
diAGNOSiS Of fAMiliAl hyPERchOlEStEROlAEMiA.
William T Wrighta, Pádraig J Harta, Shirley V Heggartyb, Ian S Youngc, D 
Paul Nichollsc, Colin A Grahama
a  Northern Ireland Regional Genetics Centre, Belfast.
b  Genomic Core Technology Unit, Queen’s University, Belfast. 
c  Regional Lipid Clinic, Belfast.
An iPLEXTM assay that includes 57 mutations in the LDLR, APOB and PCSK9 
genes, gives a 75% detection rate for definite Familial Hypercholesterolaemia 
(FH) and was tested to determine if this technology was applicable to routine 
genetic diagnostics. The iPLEXTM MassARRAY platform (Sequenom GmbH) 
utilizes single base extension of mass modified terminators using MALDI-
TOF mass spectrometry to analyse primer extension products, determining 
SNPs accurately, rapidly and economically.
The iPLEXTM test was verified by analyzing 150 FH samples with a previously 
characterized mutation and 96 no-mutation control samples. Mutations were 
identified in all 150 FH mutation-positive samples using the iPLEXTM assay, 
with 96% directly called by the software. The false positive rate was 0.015%, 
and the overall specific mutation assay failure rate was 2.1%. 
116 hyperlipidaemia patients with elevated cholesterol levels were tested 
by the FH iPLEXTM assay, with 21 (18%) having mutations identified.  This 
pick-up rate would be significantly increased were the patients to be selected 
using the Simon Broome criteria.  The FH iPLEXTM system chip can test up to 
86 patients in approximately two days at a cost of less than €10 per sample, 
and so provides a useful and efficient first-line screen for FH.
P17. chAllENGES iN GENEtic cOuNSElliNG ARiSiNG fROM 
thE RiSK Of MultiPlE GENEtic cONditiONS iN A SiNGlE 
fAMily.
Alana Ward, Cliona deBaroid, Sally-Ann Lynch.
National  Centre  for  Medical  Genetics,  Our  Lady’s  Children’s  Hospital 
Crumlin, Dublin 12, Ireland
During a Genetics consultation ascertaining a family history can be a delicate 
process.  Three families in whom several separate genetic risks were present 
and the complexity of the counselling required are discussed.  Family 1 were 
referred due to a child born with Trisomy 21.  The couple also had a family 
history of SMA and CF and advanced maternal age was also a consideration.   
Family 2 were referred due to a history of X-linked Adrenoleukodystrophy.   
A child had also died neonatally due to SMA.  Family 3 were referred due 
to a diagnosis of Fragile X.  Further exploration showed a relative affected 
with Huntington Disease and a neonatal death which revealed, although was 
unexplained by, a Robertsonian translocation.  
Each of these families came to the Genetics clinic with a single genetic 
condition as their primary focus.  Introducing the concept of additional 
significant yet diverse risks in a clear and understandable manner presented 
a number of practical counselling challenges particularly with regard to 
communicating burden of risk. 
P18. NON-MOSAic tRiSOMy 22 iN A livE-BORN MAlE.
Alex Magee1, A Beckett2, M Humphreys2, A Harper3, F Casey4, F Stewart1
1  Regional Genetics Service, Belfast City Hospital, Belfast BT9 7AB. 
2  Regional Genetics Laboratories, Belfast City Hospital, BT9 7AB. 
3  Royal Jubilee Maternity Hospital, Belfast BT12 6 BE. 
4  Paediatric Cardiology Service, Royal Belfast Hospital for Sick Children, 
Belfast BT12 6BE
Non-mosaic trisomy 22 is recognised as a common cause of first trimester 
miscarriage; survival beyond this is rare. 
In this case, a baby boy was delivered at 39 weeks by caesarean section to a 
39 year-old mother, and survived approx 60 minutes.  She had 2 first trimester 
miscarriages, a daughter with multiple problems including microcephaly, 
septo-optic dysplasia and severe epilepsy (46,XX), and a healthy 23 year-old 
daughter from a previous relationship.  Scan at 14 weeks was normal, but 
rescan at 26 weeks showed IUGR.  Further assessment at 27 weeks identified 
abdominal left isomerism; biventricular AV connection, large VSD, single 
outlet right ventricle; oligohydramnios and severe IUGR.  Amniocentesis 
was declined. 
Birth  weight  was  1390g.    He  was  dysmorphic,  with  dolicocephaly, 
hypertelorism, epicanthic folds and an open mouth.  The palate was narrow 
and high, with thickened gums. He had very low set ears; the right ear was 
rudimentary and the left dysplastic with a preauricular tag.  The anus was 
posteriorly placed and imperforate.  Post-mortem was declined.  A blood 
sample was taken for karyotyping and non-mosaic trisomy 22 confirmed.
Survival to term and significant life expectancy in trisomy 22 is usually 
associated  with  mosaicism.    Identification  of  non-mosaic  cases,  and 
recognition of the poor prognosis, is important to allow clinicians and parents 
to plan appropriate management.
P19. dOES NOGGiN cAuSE twiNNiNG?
Miriam Russell1, Sally Ann Lynch1
1  National Centre for Medical Genetics, OLCHC, Crumlin, Dublin 12.
Human monozygotic twins account for 1 in 250 live births and are considered 
genetically identical. The origin of MZ twins is attributed to two or more 
daughter cells of a single zygote undergoing independent mitotic divisions, 
leading  to  independent  development  and  births.  To  date,  the  cause  of 
monozygotic twins remains unknown. Human beings and armadillos are the 
only mammals where monozygosity occurs.
We  have  previously  reported  two  unrelated  sets  of  monozygotic  twins 
from spontaneous dizygotic triplet pregnancies, with a clinical phenotype 
of facio audio symphalagism (FAS).  The dizygotic sibling of each triplet 
set has a normal phenotype. Spontaneuosly conceived triplet pregnancies 
occur in 1 in 6500 births in the Republic of Ireland. Noggin mutations occur 
in approximately 1 in 10000 births. The probability of FAS recurring in 
monozygotic twins from a triplet pregnancy is therefore highly unlikely. 
A nonsense mutation in the Noggin (NOG) gene located on chromosome 17 
q22 has been implicated as a causative factor in FAS. Mutations in GDF5 on 
chromosome 20q11.2  have also been identified in this syndrome. 
We examine the correlataion between the phenotype of FAS and Noggin 
and monozygosity to detemine if a Noggin mutaion predisposes to twinning 
or indeed if there is an underlying mechanism that might cause noggin to 
influence monozygotic twinning. It is documented that monozygotic twins 
show  DNA  methylation  disturbance,  for  example,  Beckwith  Weideman 
Syndrome (BWS) show excess of monozygotic twins (often discordant for 
BWS) more than by chance. Methylation disturbance has been shown to be 
the causative factor. As there is a CpG island present in the Noggin gene, one 
possibility would be to explore the methylation status of Noggin to determine 
if there are methylation irregularities that may play a role in twinning. 
The coding region of Noggin was amplified in two overlapping segments. 
Sequencing  was  carried  out  using  the  ABI  Prism  BigDye  Terminator 
Sequencing Kit. Both sets of twins returned normal results at the Noggin © The Ulster Medical Society, 2009.
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DNA sequencing level. GDF5 sequencing is currently ongoing. Monozygosity 
of twins was confirmed using the Promega PowerPlex 16 kit.  
DNA methylation is currently being assesed in both sets of monzygotic 
twins and, where available, unaffected siblings, by using both methylaytion 
microarray chip and BiSulphite modification PCR. 
We  propose  to  examine  the  methylation  irregularities  of  Noggin,  and 
to  determine  if  there  is  a  correlation  between  noggin  methylation  and 
twinning.
P20.  thE  dESiGN  Of  A  thERAPEutic  StRAtEGy  fOR 
dOMiNANtly iNhERitEd REtiNitiS PiGMENtOSA fOR uSE 
iN lARGER ANiMAl MOdElS. 
CA Kilty, M O’Reilly, S Millington-Ward, PF Kenna, N Chadderton, A Palfi, 
P Humphries, GJ Farrar.
Smurfit Institute of Genetics, Trinity College Dublin
Retinitis  Pigmentosa  (RP)  represents  a  group  of  retinal  disorders  that 
results in progressive loss of vision due to photoreceptor cell death.  Over 
100 mutations have been identified in the rhodopsin gene that gives rise 
to autosomal dominant (ad) RP. One therapeutic approach which has been 
suggested for adRP, utilises suppression and replacement. Both wild-type and 
mutant rhodopsin alleles are suppressed and simultaneously a replacement 
gene, refractory to the suppression agent is delivered. This strategy has 
previously been employed in our laboratory using RNA interference (RNAi) 
as the suppression agent. In this study we decided to design a strategy for use 
in a porcine model of RP. Two siRNA molecules were designed to target both 
human and porcine rhodopsin. Initially these were tested in vitro in HeLa 
cells and one of these siRNAs was found to suppress rhodopsin significantly 
both at the RNA and protein levels. We are currently converting this siRNA 
into both shRNA and miRNA formats in order to test suppression in vivo in 
a mouse RP model carrying a mutant porcine rhodopsin transgene. 
P21. withdRAwN
P22.  AAv-MEdiAtEd  chRONic  OvER-ExPRESSiON  Of 
SNAP-25 iN Adult RAt dORSAl hiPPOcAMPuS iNcREASES 
ExtRAcEllulAR  GlutAMAtE  ANd  iMPAiRS  SPAtiAl 
lEARNiNG.
Alex G McKee1, Niamh C O’Sullivan2, Naomi Chadderton1, Jennifer S 
Loscher2, Sean O’Shea2, Mary Moran2, Olive McCabe2, Alfonso Blanco 
Fernández3, Menelas N Pangalos3, Ciaran M Regan2, William T O’Connor2§, 
Peter Humphries1, G Jane Farrar1,5, Keith J Murphy2,5
1  Applied Neurotherapeutics Research Group, Smurfit Institute of Genetics, 
Trinity College Dublin, Dublin 2, Ireland.
2  Applied Neurotherapeutics Research Group, UCD School of Biomolecular 
and Biomedical Science & 
3  Flow  Cytometry  Core  Facilities,  UCD  Conway  Institute,  University 
College Dublin, Belfield, Dublin 4, Ireland. 
4  Discovery Neuroscience, Wyeth Research, Princeton, NJ 08543, USA.
5  These authors contributed equally to this work  § Present address: Graduate 
School of Medicine, University of Limerick, Limerick, Ireland
Long-term  memory  is  formed  by  alterations  in  glutamate-dependent 
excitatory  synaptic  transmission,  which  is  in  turn  regulated  by  SNAP-
25, a key component of the SNARE complex essential for exocytosis of 
neurotransmitter-filled synaptic vesicles. Both reduced and excessive SNAP-
25 activity has been implicated in various disease states that involve cognitive 
dysfunctions such as ADHD, schizophrenia and Alzheimer’s disease. Here 
we provide evidence that over-expression of SNAP-25 in the adult rat dorsal 
hippocampus, achieved by infusion of a recombinant AAV vector, causes 
selective impairment in spatial memory acquisition in the water maze task. 
This effect was accompanied by a specific and significant increase in the 
levels of extracellular glutamate detectable by microdialysis. These results 
suggest that chronic high expression of SNAP-25 in a significant proportion 
of  the  glutamatergic  hippocampal  neurons  creates  a  high  background 
transmission  state  that  obscures  the  spatial  memory  trace  and  prevents 
accurate synapse selection during the consolidation phase.
P23. A 5q dElEtiON with A cRyPtic Etv6/RuNx1 iN A cASE 
Of childhOOd All. 
SE McNerlan1, P McGrattan1, C Cairns2, SI Dempsey2, MW Humphreys1.
Regional Genetics Service, Belfast City Hospital, Belfast BT9 7AB
Department  of  Haematology,  Royal  Belfast  Hospital  for  Sick  Children, 
Belfast BT12 6BE
A 7year old girl presented with pallor, puffy face and pain in her foot. 
Haematological findings showed a WCC of 43.8x109/l, platelets 31x109/l, 
haemoglobin 5.2g/dl, with 87% blasts. Bone marrow revealed an L1 FAB 
type with flow cytometric results in keeping with precursor B-ALL (common 
ALL).
Cytogenetic  analysis  showed  del(5q)  and  del(12p)  in  6/20  (30%)  cells 
analysed. Interphase FISH analysis revealed the presence of  ETV6/RUNX1 
rearrangement in 193/201 (96%) cells, and of these 161 (80%) showed a 
deletion of the non-translocated chromosome 12 homologue. FISH using an 
EGR1 probe for 5q31 showed a del(5q) in 96/200 (48%) of cells examined.
The  ETV6/RUNX1  rearrangement  is  a  recurrent  finding  in  childhood 
ALL, and is associated with a favourable prognosis. Deletions of 12p are a 
common secondary finding in childhood ALL, however, deletions of 5q are 
more commonly associated with myeloid disease and have only rarely been 
reported in ALL. 
As the percentage of cells containing the t(12;21) (96%) was so much higher 
than those containing del(5q) (48%) and also slightly higher than those 
containing del 12p (80%), this might suggest that the del 5q, and possibly 
the del(12p), represent secondary abnormalities in this patient. Secondary 
abnormalities are generally associated with disease progression and therefore 
influence disease prognosis. The significance of this finding in this particular 
case remains to be determined.
P24.  dEvElOPMENt  Of A  REtiNitiS  PiGMENtOSA  (RP) 
GENOtyPiNG  MicROARRAy ANd  dEtEctiON  Of  KNOwN 
ANd NOvEl MutAtiONS iN A cOhORt Of NORthERN iRiSh 
RP PAtiENtS. 
GR Clark, D Muszynska, S Alexander, P Crowe, J O’Neill, GJ McKay, G 
Silvestri, DAC Simpson
Centre for Vision Science, Queen’s University Belfast, Northern Ireland
The  inherited  retinal  disease  Retinitis  Pigmentosa  (RP)  is  extremely 
genetically  heterogeneous,  with  20  genes  implicated  in  non-syndromic 
recessive RP to date. However, it is very difficult to identify the causative 
mutation  when  a  new  patient  presents.  Therefore,  we  have  developed 
an Affymetrix  customseq  microarray  capable  of  resequencing  reported 
mutations and the exons within which they are found. In total 30 kbp from 
22 genes were tiled on the array. Approximately 100 amplicons spanning the 
regions of interest were amplified from 35 DNA samples from recessive or 
sporadic RP patients. These were pooled, fragmented, labelled and hybridised 
to  the  genechip  according  to  the  manufacturer’s  protocol.  Results  were 
analysed using the GeneChip DNA Analysis Software (GDAS, Affymetrix). 
An average call rate of 91% was achieved for all the sequences analysed. A 
total of eleven known mutations in RGR, USH2A and CRB1 and a number of 
novel sequence variants were detected. This microarray platform is therefore a 
rapid and effective screen for RP mutations and provides a new tool to include 
in screening strategies. It is anticipated that the improved detection of RP 
mutations will facilitate genotype : phenotype correlations, better prognosis 
and application of therapeutic interventions such as gene therapy.
P25.  dEtEctiON  Of  A  12P13  chROMOSOME  ANOMAly 
iNvOlviNG  Etv6  At  RElAPSE  iN  AN  AdOlEScENt 
PRESENtiNG with cytOGENEticAlly NORMAl, flt3-itd+, 
tyPE A NPM1+ dE NOvO AMl (M5 fAB-tyPE).
P McGrattan1, MW Humphreys1, KI Mills2, AF Gilkes3 MF McMullin4
1  Department of Medical Genetics, Belfast City Hospital, Belfast Health & 
Social Care Trust, Lisburn Road, Belfast, Northern Ireland, BT9 7AB. 
2  Centre for Cancer Research and Cell Biology, Queen’s University of 
Belfast,  School  of  Biomedical  Sciences,  97  Lisburn  Road,  Northern 
Ireland, BT9 7BL 
3  Department of Haematology, School of Medicine, Cardiff University, 
Wales, CF14 4XN. 
4  Department of Haematology, Belfast City Hospital, Belfast Health & 
Social Care Trust, Lisburn Road, Belfast, BT9 7AB, Northern Ireland.
Although pre-treatment MRC AML 10 cytogenetic data has been extremely 
useful for predicting initial response to chemotherapy, remission duration and 
overall survival in AML, several studies now indicate that cytogenetically 
normal AML (CN-AML) is in fact represented by underlying molecular 
mutations. The clinical impact of NPM1+ (favourable) and FLT3 (adverse) 
mutations in younger de novo CN-AML adults is now well established. © The Ulster Medical Society, 2009.
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12p13  chromosomal  rearrangements  associated  with  treatment  related 
AML have only been reported in 6 cases and are generally associated a poor 
median survival (~4 months). To our knowledge, all 6 patients had 12p13 
rearrangements resulting from translocations in which a 5’ETV6-3’partner 
fusion gene was generated. 
We describe a CN-AML (M5 FAB-type) 16 year old presenting with two 
FLT3-ITD mutations and an NPM1 (Type A) mutation. She received intensive 
chemotherapy but relapsed after 10 months. Despite being FLT3-ITD-, NPM1+, 
a pericentric inversion of one chromosome 12 homologue was detected with 
breakpoints at 12p13 and 12q13. Metaphase FISH studies confirmed ETV6 
gene involvement.
To our knowledge, this is the first reported case of a 12p13 rearrangement 
resulting from a pericentric inversion of chromosome 12 at relapse appearing 
with a persistent NPM1 mutation and loss of FLT3-ITD.
P26. GENOME-widE ASSOciAtiON (GwA) Study Of AttENtiON 
dEficit hyPERActivity diSORdER-cOMBiNEd tyPE (Adhd-
ct); AdjuStMENt fOR GENEtic hEtEROGENEity iN lARGE 
MulticENtRE StudiES.
Richard Anney, Matthew Hill, Colm O’Dushlaine, Elaine Kenny, the IMAGE 
Consortium, Michael Gill.
Department  of  Psychiatry,  Neuropsychiatric  Genetics  Research  Group, 
Institute of Molecular Medicine & Trinity College Dublin, Ireland.
As modern humans have spread throughout the world, allele frequencies and 
linkage disequilibrium (LD) have become more varied between populations.   
Population admixture is a major source of bias in the case-control study 
design. Family-based designs, such as the Transmission Disequilibrium Test, 
have been used to limit this phenomenon.  However, the power of the TDT 
to detect disease susceptibility loci (DSL) can be influenced by population 
admixture through its impact on the degree of LD between the genetic marker 
and the DSL.
We have examined the population clustering of a large multicentre study 
of  approximately  950  simplex  ADHD-CT  families  collected  from  a 
white-European population.  We have applied selection criteria to reduce 
heterogeneity at the clinical and genetic level.  
We present data from this pre-cleaning step and discuss the implications to 
large multicentre studies.  Moreover, we present the results of the application 
of this data to GWA data using data generated from the IMAGE ADHD-CT 
study.  These data are examined at the marker, gene and hypothesis-free 
and hypothesis-driven gene-network analysis.  Moreover, we examine the 
functional variation of genes tagged by associated SNP markers.
P27. PARtiAl tRiSOMy fOR thE 17q SuBtElOMERE REGiON: 
fiRSt cASE REPORt ANd REviEw Of thE litERAtuRE.
V McConnell, G Smith, S McCullough
Northern Ireland Regional Genetics Service, Belfast City Hospital, Belfast 
Health and Social Care Trust, Northern Ireland.
Complex and isolated partial trisomy 17q subtelomere patients have rarely been 
reported in the literature. We report a patient with an isolated partial trisomy of 
the 17q subtelomere region. The patient first presented for genetics assessment 
aged 13 months with abnormal head shape, subtle dysmorphism and normal 
development. Cranial radiology was normal. Reassessment at 8 years and 9 
months showed the patient to have a specific learning disability, mild truncal 
hypotonia, gross and fine motor skills delay, atrial septal defect, trigonocephaly 
with prominent metopic ridge and dysmorphism. There is a history of similar 
learning difficulties and motor delay in an older sister. Chromosome analysis 
and 22q11 and 2q37 FISH deletion studies were normal. Subtelomere testing 
using multiplex ligation-dependent probe amplification showed a duplication 
of the 17q subtelomere probe region. Further FISH testing demonstrated that 
the patient had an unbalanced translocation between chromosomes 13p and 
17q resulting in a partial trisomy for the 17q subtelomere region. Parental 
chromosomes were normal.  To our knowledge, this is the first reported patient 
with an isolated partial trisomy of 17q subtelomere. It also demonstrates the 
value of reassessment of patients in light of new technology.
P28. NOvEl SPlicE SitE MutAtiONS AS thE cAuSE Of fAP-
RElAtEd cANcER iN twO fAMiliES.
K Sweet, B McIlhatton, V McConnell, P Logan, C Graham
Northern Ireland Regional Genetics Service, Belfast City Hospital, Belfast 
Health and Social Care Trust, Northern Ireland.
Familial Adenomatous Polyposis (FAP) is an autosomal dominant inherited 
disease which is characterized by the presence of adenomatous polyps in the 
colon and rectum. Here we describe two novel mutations in the adenomatous 
polyposis coli (APC) gene in two separate families which have been shown 
to affect RNA splicing and be the cause of the FAP-related cancer.
In one family, a 62-year old woman diagnosed with Attenuated FAP was 
referred for testing.  DNA sequencing of the APC gene revealed a recently 
identified  mutation  c.423G>T  (p.R141S)  in  exon  4.   The  mutation  was 
subsequently  found  in  the  proband’s  sister,  niece  and  nephew.    In  the 
second family, a 51-year old male diagnosed with an adenocarcinoma of 
the right colon and the presence of multiple polyps (50+) in the whole 
colon was tested.  DNA sequencing of APC gene revealed a c.1409-5A>G 
(p.G470VfsX15) mutation at the intron/exon boundary of exon 11.  Reverse 
transcriptase-PCR demonstrated at the RNA level that both mutations affected 
the splice site.  One mutation resulted in deletion of exon 4 of APC gene 
and the other mutation created an alternative splice acceptor site at the 5’ 
end of exon 11.
P29.  A  ROlE  fOR  GENEtic  vARiAtiON  At  hOMER2  iN 
SchizOPhRENiA:  fuRthER  EvidENcE  fROM  iRiSh ANd 
OthER EuROPEAN POPulAtiONS. 
William P Gilks1, Emma Allott1, Michael Gill1, Aiden P Corvin1, Derek W 
Morris1 and the International Schizophrenia Consortium.
1  Neuropsychiatric Genetics Research Group, IMM and Dept. of Psychiatry, 
Trinity College Dublin, Ireland.
Schizophrenia (SZ) is a complex disorder of uncertain aetiology but which 
may involve dysfunction at glutamatergic synapses of the brain. Based-on 
linkage and gene expression data we identified HOMER2 (OMIM 604799) as 
a plausible candidate gene for SZ. Homer2 is enriched at excitatory synapses 
where  it  links  glutamate  receptors  to  the  cytoskeleton.  We  previously 
reported allelic and haplotype evidence of association at HOMER2 in a 
sample of 375 cases and 812 cases from Ireland (Gilks et al. Ulster Med J 
2008;77(1):66[S7]). The best result was at rs869498 (p=0.016, OR 1.39)
The  International  Schizophrenia  Consortium  conducted  a  genome-wide 
association study of schizophrenia using 3,380 cases and 3,593 controls 
from Europe (Affymetrix 5.0 and 6.0 platforms). Across HOMER2, 44 SNPs 
were genotyped of which 11 were associated with disease status at p<0.05. 
Of our four previous LD-independent associations, two (at rs2306428 and 
rs869498) were reproduced by proxy (rs17158194, p=0.001, OR 1.15 and 
rs17158155, p=0.02, OR 1.27 respectively). We have also found evidence 
for association with genes regulated by HOMER2 in this dataset. These data 
support a role for HOMER2 in SZ susceptibility and further genetic and 
functional studies are warranted to investigate molecular pathways involving 
HOMER2 in SZ.
P30.  AllElic  ExPRESSiON  iMBAlANcE  ANAlySiS  Of 
PSychOSiS SuScEPtiBility GENES.
Emma Quinn, Matthew Hill, Richard Anney, Michael Gill, Derek Morris, 
Aiden Corvin.
Neuropsychiatric Genetics Research Group, Dept. of Psychiatry and Institute 
of Molecular Medicine, Trinity College Dublin, Ireland.
Schizophrenia  and  bipolar  disorder  are  complex  psychiatric  disorders 
affecting approximately 1-2% of the population worldwide. Evidence from 
twin and family studies indicate that both disorders are highly heritable. 
However,  identifying  candidate  genes  associated  with  the  disorders  has 
proved difficult due their complex genetic aetiology. The advent of genome 
wide association studies (GWAS) has made is possible to rapidly identifying 
potential candidate genes associated with common disorders. It now remains 
to further investigate these regions to elucidate the putative functional roles 
of susceptibility variants. As part of international consortia for schizophrenia 
and bipolar disorder research we are investigating several genes (ZNF804A, 
CACNAC1 and ANK3) that have been significantly associated in GWAS 
for possible functional variants. Genetic variants that have a regulatory role 
in gene expression can be investigated by measuring Allelic Expression 
Imbalance (AEI), whereby the expression levels of two alleles from a marker 
SNP can be compared in heterozygous individuals. The presence of AEI 
indicates cis acting factors that influence gene transcription or processing. 
Heritable differences in gene expression are thought to contribute to the 
susceptibly of many complex diseases and could potentially influence an 
individuals susceptibility to schizophrenia. 
P31. lARGE ScAlE PAthwAy-BASEd ANAlySiS Of GENOME-
widE  ASSOciAtiON  Study  dAtA:  iMPlicAtiONS  ANd 
APPlicAtiONS. © The Ulster Medical Society, 2009.
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Elaine Kenny, Colm T O’Dushlaine, Derek W Morris, Richard JL Anney, 
Michael Gill, Aiden P Corvin.
Neuropsychiatric Genetics Research Group, IMM and Dept. of Psychiatry, 
Trinity College Dublin, Ireland.
With the advent of whole genome association studies, listing of all results 
for up to 1 million SNPs is not feasible and usually only the top associated 
SNPs are listed/ analysed in-depth. Such focused analysis may hide the 
biology behind disease.
To overcome this problem we have designed a novel SNP ratio test (SRT) 
to look at all significant SNPs in a biologically relevant format. The SRT 
analyses the significant SNPs that lie within genes in KEGG pathways, and 
looks for enrichment of significant to non-significant signal in one pathway 
compared to all other pathways. 
We applied this method to 7 whole genome association studies testing which 
pathways were significantly enriched for association signal in the different 
datasets. The association data was sourced from the Wellcome Trust Case 
Control Consortium that carried out a joint whole genome association study 
examining 2,000 individuals for each of 7 major diseases using a shared set 
of 3,000 controls.
It is striking to note that obvious pathway candidates for certain diseases 
e.g. Type I diabetes mellitus pathway and Type II diabetes mellitus pathway 
were both found to be significant in the Type I diabetes and Type II diabetes 
datasets respectively. 
P32.  NOvEl  GENOMic  PAthwAy ANAlySiS  Of  GENOME-
widE ASSOciAtiON  StudiES:  idENtificAtiON  Of  ERBB 
SiGNAlliNG AS A SuScEPtiBility PAthwAy iN PARKiNSON’S 
diSEASE
Colm T O’Dushlaine, Elaine Kenny, Carlos Pinto, William P Gilks, Michael 
Gill, Derek W Morris, Aiden Corvin.
Neuropsychiatric Genetics Research Group, IMM and Dept. of Psychiatry, 
Trinity College Dublin, Ireland.
Background: Systems-based approaches to mining complex genome-wide 
association study (GWAS) data have recently gained prominence. We have 
developed, and evaluate the performance of a novel SNP ratio test (SRT), 
which compares observed to expected ratios of significant to non-significant 
SNPs  within  versus  outside  pathways,  in  two  Parkinson’s  disease  (PD) 
GWAS datasets. 
Results: In both PD datasets the SRT identified significant evidence for 
involvement of the “ErbB signalling pathway” in PD aetiology. Comparison 
with an alternative method of pathway analysis, genomic pathway mining 
(GPM),  provided  convergent  statistical  support  for  involvement  of  this 
pathway in PD. The erbB signalling pathway performs multiple neuronal 
functions and has been linked to many neuropsychiatric disorders including 
Alzheimer’s disease, schizophrenia and PD. 
Conclusions: We identify the SRT as a valuable method of rapidly identifying 
pathway signals in GWAS data, which can be followed up using more detailed 
pathway modelling to identify the relative contributions of different SNPs to 
susceptibility. This approach may be particularly valuable for complex genetic 
disorders of uncertain aetiology and is applicable to any available pathway 
resources. In PD, further replication and characterisation of involvement of 
erbB signalling pathways is warranted in larger, more densely genotyped 
datasets.
P33.  NO  EvidENcE  Of  ASSOciAtiON  BEtwEEN 
POlyMORPhiSMS iN A 2P25 GENE-cluStER with vARiAtiON 
iN BONE MiNERAl dENSity
KG Hegarty1,2, M Daly1, F Shanahan1, MG Molloy1. 
1  Department of Rheumatology and Sports Medicine, National University 
of Ireland, Cork, Ireland.  
2  Department of Medicine, National University of Ireland, Cork, Ireland.  
3  Alimentary Pharmabiotic Center, National University of Ireland, Cork, 
Ireland.
Osteoporosis is a complex skeletal disease, under strong genetic influence, 
that alters the mineral composition of bone resulting in a loss of bone mineral 
density (BMD), variation in bone strength and elasticity which leads to an 
increase in non-traumatic fractures.  We chose to fine map a gene-cluster 
at 2p25 to elucidate potential genetic associations with BMD variation.   
The potential candidate genes in this 387.6kb region are the development 
and differentiation enhancing factor 2 (DDEF2), integrin beta 1 binding 
protein 1 (ITGB1BP1) and a disintegrin and metalloproteinase domain 17 
(ADAM17).  Haploview was used to determine the gene-cluster linkage 
disequilibrium structure and select tagSNPs.  The Kbioscience Genotyping 
service was employed to determine the SNP genotypes in 552 individuals 
from 251 families (192 pedigrees) ascertained through probands with low 
BMD (T<-1.5).  Sixteen tagSNPs captured 70.0% of the HapMap validated 
variation across the gene-cluster region.  None of the SNPs significantly 
deviated from HWE.  Age, height, weight and sex were included as covariates 
in all subsequent statistical analysis.  There was no evidence of population 
stratification, linkage or association observed between these tagSNPs or 
haplotypes and the BMD phenotypes tested.  Denser SNP genotyping and 
replication in an independent study is required to support these results.
P34. EPiGENEtic SuPPRESSiON Of ctNNA3 ANd itS NEStEd 
GENE  lRRtM3  iN  uROthEliAl  cARciNOMA  Of  thE 
BlAddER (ucB).
Maria  Meehan1,  Jenny  Watson,1  Emma  Gallagher1, Alo  Mc  Goldrick1, 
Michèle Harrison2, Elaine Kay3,  John Fitzpatrick4, Peter Dervan2 Amanda 
Mc Cann1.
1  UCD School of Medicine and Medical Sciences (SMMS), College of 
Life Sciences, UCD Conway Institute of Biomolecular and Biomedical 
Research, Belfield, Dublin 4. 
2  Department of Pathology Mater Misericordiae Hospital, Eccles Street, 
Dublin 7. 
3  Department of Pathology, Royal College of Surgeons in Ireland, Beaumont 
Hospital Dublin 9. 
4  Department  of  Surgery,  Mater  Misericordiae  Hospital,  Eccles  Street, 
Dublin 7.
LRRTM3 is normally neuronally expressed and is located within the largest 
intron of CTNNA3 suggesting co-evolution of these two genes. LRRTM3 is 
entirely located within CTNNA3, but is transcribed in the opposite direction 
and is therefore a nested gene. Moreover, CTNNA3 is a developmentally 
imprinted gene, with preferential expression of the maternal allele, while 
LRRTM3 is not imprinted. 
Taqman® QRTPCR employing the relative quantity method was used to 
determine the mRNA levels of CTNNA3 and LRRTM3 in a series of UCB 
cell lines (HT1376, RT4, T24, TCCSUP, RT112, CAL29).  The demethyl 
transferase inhibitor 5-aza-2’deoxycytidine (DAC) was used for the chromatin 
modifying treatments of TCCSUP.   
We demonstrate that CTNNA3 and LRRTM3 are co-ordinately expressed in 
these UCB cell lines.  In TCCSUP, mRNA levels of CTNNA3 and LRRTM3 
are minimal.  However, following DAC treatment, CTNNA3 and LRTMM3 
demonstrated increased mRNA expression by 4 and 7 fold respectively. Two 
CpG islands identified in the promoter region of CTNNA3 (MethPrimer) 
show  no  evidence  of  DNA  methylation  following  sodium  bisulphite 
modification  and  sequencing.    Therefore,  the  increased  expression  of 
CTNNA3 following DAC treatment suggests indirect effects of this drug on 
this region such as the demethylation of transcription factors or transcription 
factor binding sites common to both genes. 
P35. REt vARiAtiON iN thE AEtiOlOGy Of vESicOuREtERic 
REflux. 
Niamh HN Molloy, John M Darlow, Andrew J Green , Prem Puri, David E 
Barton 
National Centre for Medical Genetics, and Children’s Research Centre, Our 
Lady’s Children’s Hospital, Crumlin, Dublin
Vesicoureteric reflux (VUR) is the retrograde flow of urine from the bladder 
towards the kidneys and is a major cause of renal failure and hypertension. 
Primary VUR is a developmental anomaly of the vesicoureteric valves and 
commonly occurs along with other developmental anomalies of the urinary 
tract in the same individual or other members of the same family. The cause 
of VUR is unknown but it often runs in families and may be inherited as 
an autosomal dominant in most cases. Some of the genes already known 
to  be  involved  in  urinary  tract  development  are  also  involved  in  other 
developmental  processes  and  therefore  their  mutation  is  liable  to  cause 
multiple anomalies and is unlikely to result in isolated VUR. RET is such 
a gene. Some mutations of RET result in multiple endocrine neoplasia, and 
others in Hirschsprung disease (defective intestinal innervation). However, a 
group in Quebec found that a single nucleotide polymorphism (SNP) in RET, 
which changes an amino-acid (p.Gly691Ser), is greatly increased in VUR, 
with a heterozygote frequency of 69% as against 29% in the healthy Quebec 
population. We present the results of a study of this SNP in VUR patients and © The Ulster Medical Society, 2009.
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healthy controls in the Irish population and discuss the implications.
P36. thE SEARch fOR GENES iNvOlvEd iN vESicOuREtERic 
REflux.
Wei San Wong, Claire McGuinness, John M Darlow, Andrew J Green, Prem 
Puri, David E Barton
National Centre for Medical Genetics and Children’s Research Centre, Our 
Lady’s Children’s Hospital, Crumlin, Dublin
Vesicoureteric reflux (VUR) is the retrograde flow of urine from the bladder 
towards the kidneys. It is common in young children and is a major cause of 
renal failure and hypertension, though the condition resolves in some as they 
grow. Primary VUR is a developmental anomaly of the vesicoureteric valves 
and is part of a spectrum of developmental anomalies of the urinary tract. 
Though a few genes are known whose mutation causes VUR in addition to 
defects of other organs (such as renal-coloboma syndrome, and branchio-oto-
renal syndrome), the cause of isolated VUR is unknown, but genetic studies 
so far suggest that it is highly genetically heterogeneous. A genome scan that 
we performed on 129 Irish families highlighted 10-15 regions of the genome 
that appeared to show linkage to the disorder, including 2 regions yielding 
non-parametric lod scores >2.5. We investigated the genes and non-coding 
regulatory elements in these regions to develop a priority list of places in 
which to search for possible pathogenic mutations, and present the results 
of our search so far.
P37.  PhENOtyPE ANd  GENOtyPE ANAlySiS  Of  fAMiliAl 
PERiOdic PARAlySiS iN iRiSh fAMiliES. 
SB Kelly1, NA Parfrey2, AM Ryan1, CK Hand2.
1  Department of Neurology, Cork University Hospital, 
2  UCC Department of Pathology
The familial periodic paralyses are caused by autosomal dominant mutations 
of skeletal muscle ion channels leading to altered membrane excitability. 
The disorders are characterised by episodes of limb weakness and paralysis 
lasting minutes to hours. Hyperkalaemic periodic paralysis (Hyper PP) is 
caused by missense mutations in the skeletal muscle sodium channel gene, 
SCN4A. Hypokalaemic periodic paralysis (HypoPP) is due to mutations in 
the calcium channel gene CACNA1S (HypoPP1) and mutations in SCN4A 
(HypoPP2). 
We aimed to identify patients and families with periodic paralysis in an Irish 
population and characterise them clinically and genetically.
Patients  were  recruited  through  a  neurology  tertiary  referral  centre. 
Detailed clinical and family history, physical examination and specialised 
neurophysiologic examination were performed in each case. Genomic DNA 
was  extracted  and  screening  was  performed  for  known  and  novel  gene 
mutations.
To date we have identified 4 families with HyperPP and 1 with HypoPP 
(genetically confirmed elsewhere).  All of the HyperPP families have the same 
SCNA4 Met1592Val mutation, but are phenotypically heterogeneous.  One is 
a four-generation pedigree with an unusually prolonged attack duration. The 
HypoPP patient has a de novo but previously reported SCNA4 mutation. 
P38.  il18  ANd  il2  POlyMORPhiSM  iN  PSORiASiS 
SuScEPtiBility iN thE iRiSh POPulAtiON. 
Anthony W Ryan1, Kutaiba Al-Jubury1, Graham Turner1, Phil Gallagher2, 
Alan Irvine1, Oliver Fitzgerald2, Brian Kirby2, Ross McManus1
1   Department of Clinical Medicine and Institute of Molecular Medicine, 
Trinity College, Dublin, Ireland. 
2  St Vincent’s University Hospital, University College, Dublin, Ireland
Psoriasis is an inflammatory disease of the skin and joints with a prevalence 
of up to 2% in European populations. IL18 is a pro-inflammatory cytokine, 
which promotes Th1 T-cell development by inducing γ-interferon. Genetic 
variation in this gene has been implicated in the pathogenesis of several 
autoimmune  conditions,  including  inflammatory  bowel  disease,  type  1 
diabetes, atopic eczema and asthma. There is some evidence that IL18 may 
play a role in psoriasis. rs6840968 is a single nucleotide polymorphism 
(SNP) within the IL2/IL21 region of chromosome 4q27, which has recently 
been associated with Type I Diabetes, Rheumatoid Arthritis, Graves’ Disease 
and Celiac Disease. The functional relevance of the IL2 and IL21 genes in 
inflammatory and autoimmune conditions is highlighted by the role of these 
cytokines in T-cell activation and development. We have genotyped IL18 
rs187238 (IL18-137) and IL2/IL21 rs6840968 in 231 ethnically uniform 
Irish patients with psoriasis and 871 Irish controls. Both loci conformed to 
HWE in both populations. Both loci showed evidence of association with 
psoriasis in this population (IL18 rs187238, Odds Ratio 0.61 [0.44 – 0.86], 
χ2 = 8.99, P = 0.0027; IL2/IL21 rs6840978, Odds Ratio 0.67 [0.48 – 0.92], χ2 
= 6.41, P = 0.01134, for carrier status of the minor allele in both cases). This 
latter value for IL2/IL21 rs6840978 is similar to a recent study of psoriasis 
susceptibility for the same SNP in UK and US populations (OR = 0.77 [0.62 
– 0.95] and OR = 0.81 [0.68 – 0.96], respectively), for the same allele and 
direction, substantiating existing evidence that the IL2/IL21 haplotype block 
represents a risk factor for the development of psoriasis.
P39. A  REtROSPEctivE Audit  Of AutiSM  REfERRAlS tO 
thE  NORthERN  iRElANd  REGiONAl  GENEticS  SERvicE 
BEtwEEN 1988-2008.
C Harris, V McConnell
NI. Regional Genetics Service, Belfast City Hospital, Belfast Health and 
Social Care Trust
Autistic  spectrum  disorder  (ASD)  comprises  impairment  in  the  three 
core domains of social interaction, language development and behaviour. 
Prevalence  has  increased  fourfold  in  the  past  ten  years,  likely  due  to 
heightened awareness and broader diagnostic criteria. Aetiology is primarily 
unknown with neurological, metabolic and genetic factors responsible for 
5-10%. 
Due to the significant increase in ASD referrals to the Genetics Service a 
retrospective audit of ASD referrals over the last 20 years was completed 
to develop guidelines for referrers. Referral details, genetic investigations 
completed, presence of a family history and confirmation of ASD diagnosis 
were some of the features analysed in the referral, in addition to the outcome 
of the genetic assessment.
Of the cohort, 60% were familial, 15% isolated and 25% associated with 
congenital abnormality and or learning disability in the referral letter.   32% 
had genetic investigation prior to referral. After genetic assessment, 47% 
were familial, 14% genetic, 39% of unknown aetiology.
We recommend that ASD referrals to the Genetics Service should have the 
following criteria (1) confirmation of the ASD phenotype (2) completion of 
chromosomal analysis and Fragile X studies (3) positive family history of 
learning disability / ASD and /or (4) dysmorphic features / other congenital 
abnormality.